Opportunity ID: 338504

General Information

Document Type: Grants Notice
Funding Opportunity Number: PAR-22-115
Funding Opportunity Title: Research on Community Level Interventions for Firearm and Related Violence, Injury and Mortality Prevention (CLIF-VP) (UG3/UH3 Clinical Trial Optional)
Opportunity Category: Discretionary
Opportunity Category Explanation: –
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Education
Health
Income Security and Social Services
Category Explanation: –
Expected Number of Awards: –
Assistance Listings: 93.213 — Research and Training in Complementary and Integrative Health
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: Mar 04, 2022
Last Updated Date: Mar 04, 2022
Original Closing Date for Applications: Apr 22, 2022
Current Closing Date for Applications: Apr 22, 2022
Archive Date: May 28, 2022
Estimated Total Program Funding: –
Award Ceiling: –
Award Floor: –

Eligibility

Eligible Applicants: Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
County governments
Special district governments
Independent school districts
Public housing authorities/Indian housing authorities
Public and State controlled institutions of higher education
Native American tribal organizations (other than Federally recognized tribal governments)
State governments
City or township governments
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Small businesses
For profit organizations other than small businesses
Native American tribal governments (Federally recognized)
Private institutions of higher education
Others (see text field entitled “Additional Information on Eligibility” for clarification)
Additional Information on Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.

Additional Information

Agency Name: National Institutes of Health
Description: Violence affects people of all ages and its impact is far-reaching. It is a leading cause of death and nonfatal injuries in the United States and constitutes a major public health crisis, especially among young people, and in particular among racial/ethnic minority, sexual and gender minority (SGM) and disability populations. Firearm homicide is the third leading cause of death among persons aged 10 to 24 years and the leading cause of death among Black men (45 years of age). NIH is committed to supporting research that identifies innovative prevention approaches to reduce firearm and related violence, injury and mortality. Within the legislative mandates and limitations of NIH funding (NOT-OD-21-058, NOT-OD-21-056), this initiative will support a network of research projects to develop and test interventions at the community or community organization level that aim to prevent firearm and related violence, injury and mortality.This FOA solicits bi-phasic research projects proposed in UG3/UH3 Phased Innovation Awards Cooperative Agreement applications. Funding for the UG3 phase (phase I) will be used to demonstrate sufficient preparation, feasibility and capacity to meet foundational milestone targets specific to the work proposed. A UG3 project that meets its milestones will be administratively considered by NIH and prioritized for transition to the UH3 award phase II). Applicants responding to this FOA must address specific aims and milestones for both the UG3 and UH3 phases.
Link to Additional Information: http://grants.nih.gov/grants/guide/pa-files/PAR-22-115.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH OER Webmaster
OERWebmaster03@od.nih.gov
Email:OERWebmaster03@od.nih.gov

Version History

Version Modification Description Updated Date

Related Documents

Packages

Agency Contact Information: NIH OER Webmaster
OERWebmaster03@od.nih.gov
Email: OERWebmaster03@od.nih.gov
Who Can Apply: Organization Applicants

Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
FORMS-G Use for due dates on or after January 25, 2022 PKG00272395 Mar 22, 2022 Apr 22, 2022 View

Package 1

Mandatory forms

338504 RR_SF424_5_0-5.0.pdf

338504 PHS398_CoverPageSupplement_5_0-5.0.pdf

338504 RR_OtherProjectInfo_1_4-1.4.pdf

338504 PerformanceSite_4_0-4.0.pdf

338504 RR_KeyPersonExpanded_4_0-4.0.pdf

338504 RR_Budget_3_0-3.0.pdf

338504 PHS398_ResearchPlan_4_0-4.0.pdf

338504 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf

Optional forms

338504 RR_SubawardBudget30_3_0-3.0.pdf

338504 PHS_AssignmentRequestForm_3_0-3.0.pdf

2025-07-12T15:13:41-05:00

Share This Post, Choose Your Platform!

About the Author: